Remove 2030 Remove Documentation Remove Labelling
article thumbnail

Pharma’s strategic path to growth in the nutra maze

Express Pharma

billion by 2030, according to a GlobeNewsWire report. “It is not justifiable to compare pharma products, where a lot of work has already been done and well-documented with international harmonisation (e.g., The nutraceutical market is expanding rapidly, valued at $6.11 billion in 2024 and projected to reach $11.55

article thumbnail

The data are in – so will Gilead’s Trodelvy achieve its potential?

pharmaphorum

The company didn’t conduct a conference call to discuss the findings, but took the unusual step of publishing a frequency asked questions (FAQ) document on the study, headlined with a non-committal statement about whether the data were “clinically meaningful.” The company said it “remains confident in that goal.”